Read More Pharma Industry News Evoke Pharma stock surges 130% as QOL Medical signs definitive $11-per-share acquisition agreement Find out how Evoke Pharma’s $11-per-share acquisition by QOL Medical is reshaping specialty pharma and why investors are applauding this record premium. bySoujanya RaviNovember 4, 2025